Test Price
2,400 AED✅ Home Collection Available
Liquid Biopsy Cell‑Free BRAF Mutation Analysis in UAE
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This droplet digital PCR (ddPCR) test detects BRAF V600E/K mutations in circulating cell‑free tumor DNA (ctDNA) from a simple blood draw, enabling real‑time therapy monitoring and early recurrence detection. The assay achieves a mutant allele fraction sensitivity of ≥0.01%, providing the highest precision for actionable BRAF mutation identification.
| Feature | Our Test (ddPCR‑Based) | Closest Alternative (NGS Panel) |
|---|---|---|
| Precision (VAF Limit) | ≥0.01% mutant allele fraction | ~1–5% depending on depth |
| Methodology | Droplet Digital PCR (ddPCR) | Targeted Next‑Generation Sequencing |
| Turnaround Time | 5–7 Working Days | 10–14 Working Days |
| Clinical Focus | Actionable BRAF V600E/K mutations only | Broad panel; may require orthogonal validation |
Physician Insight & Safety Protocols
“This liquid biopsy empowers clinicians to monitor oncologic therapy dynamically. However, the results must always be correlated with imaging and clinical findings. A negative ctDNA does not exclude the presence of micrometastatic disease. Please maintain all prescribed therapies unless a qualified physician determines otherwise.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory Statement
Do not discontinue any prescribed medication or alter your treatment regimen without explicit guidance from your qualified healthcare provider. This test is designed to support clinical decision-making and should always be used in conjunction with comprehensive clinical evaluation.
Exclusion Criteria & Red Flags
- Active febrile illness (temperature >38.5°C) or untreated systemic infection.
- Severe anemia (hemoglobin <7 g/dL) or haemodynamic instability precluding safe venipuncture.
- Pregnancy – this test is not validated for prenatal screening; DHA recommends deferral.
- Seek emergency care if you experience sudden confusion, seizures, stroke-like symptoms, or acute bleeding or bruising.
- Plasma sample must be processed within 2 hours of collection – any delay compromises ctDNA integrity.
Patient FAQ & Clinical Guidance
1. What does the Liquid Biopsy Cell‑Free BRAF test detect and why is it ordered?
This test identifies BRAF V600E and V600K mutations in tumor DNA fragments circulating in your blood to guide targeted therapy selection, monitor treatment response, and detect early cancer relapse with 99.9% sensitivity.
2. How should I prepare for the blood collection?
No fasting is required; continue all prescribed medications unless your oncologist specifically instructs otherwise. Do not alter your regimen independently to ensure accurate therapeutic monitoring.
3. When will I receive my results and how are they interpreted?
Results are typically available within 5–7 working days; a board‑certified specialist will provide a telephonic interpretation, discussing the mutant allele frequency and its clinical implications.
4. Is home collection available for this test?
Yes, VIP Mobile Phlebotomy and Temperature-Controlled Cold-Chain Home Collection are available daily from 8 AM to 11 PM, ensuring sample integrity and patient convenience.
UAE Regulatory & Data Privacy Adherence
This laboratory service operates in full compliance with the following UAE federal frameworks:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Dubai Health Authority (DHA) licensing and quality standards.
All patient data is encrypted, access-controlled, and processed in accordance with international privacy best practices.
Clinical & Logistical Metadata
| Test Name | Liquid Biopsy Cell‑Free BRAF Mutation Analysis |
| Price (AED) | 2,400 |
| Turnaround Time | 5–7 Working Days |
| Sample Type / Matrix | Peripheral Blood Plasma (ctDNA) |
| Methodology Used | Droplet Digital PCR (ddPCR) |
| ICD-10-CM Code | C43.9, Z85.9 |
| LOINC Code | 92821-8 |
| DHA Facility License & Address | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA License No: 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians